Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
While its still early in human research, the pathways it targets are well-documented in metabolic science, and the results so far are promising
AOD 9604 is not associated with any adverse side effects
Prescription peptides used under medical supervision have generally favorable safety profiles in published research, though risks vary by peptide, dose, and your individual health context
We often hear concerns about the standard discard after 28 days of first use disclaimer
5-Amino-1MQs human data as of 2026 is limited to small pilot cohorts with sample sizes under 50, making AOD-9604 the better choice when established human pharmacokinetics are required for protocol design
Consider Your Health Needs When choosing between NAD and B12, think about your personal health goals
